EU CLINICAL TRIALS REGULATION/CTIS summer 2026 updates
We have left the European summer behind us and are already approaching the end of September. Hopefully, we have all enjoyed some well-deserved time off from our drug development work, even though study start-up managers are permanently chased by EU CTR/CTIS timelines.
Between operational work and annual leave, did you manage to capture these vital EU study start-up updates between June and August?
Link to the full article below.
